Syngen Biotech Co.,Ltd. (TPEX:8279)

Syngen Biotech Revenue

Syngen Biotech had revenue of 416.66M TWD in the quarter ending March 31, 2026, a decrease of -14.25%. This brings the company's revenue in the last twelve months to 2.07B, up 1.74% year-over-year. In the year 2025, Syngen Biotech had annual revenue of 2.14B with 6.10% growth.

• Revenue (ttm): 2.07B
• Revenue Growth: +1.74%
• P/S Ratio: 1.30
• Revenue / Employee: 8.37M
• Employees: 247
• Market Cap: 2.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.14B	122.89M	6.10%
Dec 31, 2024	2.01B	176.41M	9.60%
Dec 31, 2023	1.84B	-93.41M	-4.84%
Dec 31, 2022	1.93B	459.33M	31.22%
Dec 31, 2021	1.47B	159.83M	12.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error